CD8A and myeloid sarcoma: By contrast, CD8+ T cells in older MS patients express multiple immune checkpoint molecules, such as KLRG1, LAG3, and CTLA-4 [225], along with decreased expression of costimulatory molecule CD226, suggesting premature aging in CD8+ T cells [225].